A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Hideo Omi, Yoshihito Yokoyama, Hideki Mizunuma, Michiko Kaiho, Takeo Otsuki, Tadao Takano, Nobuo Yaegashi, Hiroshi Nishiyama, Keiya Fujimori, Toru Sugiyama

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)'. Together they form a unique fingerprint.

Medicine and Dentistry

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience